Related Experiment Video
Updated: Nov 24, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.7K
lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions
Evan M McCabe1, Theodore P Rasmussen2
1Department of Molecular and Cell Biology, University of Connecticut, USA.
Seminars in Cancer Biology
|December 21, 2020
Summary
Long noncoding RNAs (lncRNAs) regulate cancer stem cells (CSCs) and their epithelial to mesenchymal transition (EMT) processes. These lncRNAs show potential as cancer biomarkers and therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Epithelial to mesenchymal transition (EMT) is crucial for embryogenesis and cancer metastasis.
- Cancer stem cells (CSCs) possess multipotency and can undergo EMT, leading to invasive and metastatic properties.
- Long noncoding RNAs (lncRNAs) are non-protein-coding RNA molecules that regulate gene expression and are implicated in various cancers.
Purpose of the Study:
- To review the interplay between lncRNAs and cancer stem cell (CSC) biogenesis.
- To examine the role of lncRNAs in EMT processes within CSCs.
- To discuss the potential of lncRNAs as cancer biomarkers and therapeutic targets.
Main Methods:
- Literature review focusing on lncRNAs, CSCs, and EMT.
- Analysis of gene regulation mechanisms involving lncRNAs.
- Evaluation of lncRNAs in cancer progression and therapeutic strategies.
Main Results:
- lncRNAs play a significant role in CSC self-renewal and differentiation.
- lncRNAs are key regulators of EMT in CSCs, influencing their migratory and invasive potential.
- Specific lncRNAs are associated with cancer progression and patient outcomes.
Conclusions:
- lncRNAs are integral to CSC biology and EMT.
- lncRNAs represent promising biomarkers for cancer detection and prognosis.
- Targeting lncRNAs offers a potential therapeutic avenue for cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.4K
lncRNA - Long Non-coding RNAs
3.1K
3.1K
Metastasis
6.1K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.1K
Cancer Stem Cells and Tumor Maintenance
5.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.3K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.3K
Stem Cell Niche
5.8K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.8K

